Uriach

What Uriach does

Uriach (legal entity Grupo J. Uriach, S.L.U.) is a family-owned Spanish pharmaceutical company founded in 1838 and headquartered in Sant Cugat del Vallès, Barcelona. The company has repositioned itself entirely around the Natural Consumer Healthcare segment, operating a "house of brands" model that markets science-backed natural products — botanicals, minerals (including the proprietary Emser® salt mineral for respiratory health), and nutraceuticals — through more than 20 brand franchises such as Aquilea (general wellness), Fisiocrem (musculoskeletal), Laborest (nutraceuticals), EMS/Emsan (respiratory), Pediakid (pediatric), Biodramina (motion sickness), Fuca (digestive), Cistitus (women's health), and Halibut (dermatology). Recent 2024 acquisitions added Pascoe (Germany, high-bioavailability Vitamin C), Ineldéa/Pediakid (France), and Bebegel (Portugal, pediatric GI).

Uriach sells its products through a multi-channel go-to-market: retail pharmacies and health food stores across 11 European countries with direct subsidiary presence (Spain, Portugal, Italy, Germany, Austria, Switzerland, Romania, France, Belgium, Czech Republic, Slovakia), brand-owned e-commerce sites, and distribution partnerships that extend reach to more than 20 additional countries. The company is led by CEO Oriol Segarra, with Enrique Uriach as Chairman of the Owner's Council and Luis Cantarell as Chairman of the Board; ICG (Intermediate Capital Group) joined the Board in November 2023 as part of a strategic partnership that is funding Uriach's acquisition-led European consolidation.

Commercially, Uriach's revenue reached €476M in 2024 (up 54% from €310M in 2023) with EBITDA of €74M (up 69%), and approximately 75% of activity is now generated outside Spain versus an almost entirely Spanish footprint in 2015. Pricing is set at retail across heterogeneous brands and markets and is not publicly disclosed. The company is B Corp certified, operates with 1,300+ employees, and has set a 2027 carbon-neutrality target, signaling ESG positioning as part of its consumer brand narrative.

Name

Uriach

Legal name

GRUPO J. URIACH, S.L.U.

Website

https://uriach.com

Company type

Private

Founded year

1838

Operating status

Operating

Headcount range

251–500 employees

Short description

Uriach is a family-owned Spanish pharmaceutical company founded in 1838, specializing in Natural Consumer Healthcare. It operates a portfolio of 20+ science-backed natural brands across 11 European countries, selling through retail pharmacies, health stores, and e-commerce to health-conscious consumers.

Ownership category

akta.pro rank

Product category

Natural Consumer Healthcare

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Soap and Cleaning Compound Manufacturing (32561)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

Keywords

• Natural consumer healthcare
• Herbal medicine products
• Nutraceutical supplements
• OTC pharmaceuticals
• Phytopharmaceutical formulations

Headquarters

HQ city

Palausolitar

HQ country

Spain

HQ region

Europe

Offices7 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations, Infrastructure

Revenue model

1. Consumer Healthcare Products: Uriach generates revenue through the sale of natural consumer healthcare products across its portfolio of 20+ brands including Aquilea, Fisiocrem, Laborest, Aerored, Biodramina, and others. Products are sold through retail pharmacies, health stores, and e-commerce in 11 European countries with direct presence and 20+ countries through distribution.
2. Brand Portfolio Revenue: Revenue from diversified brand portfolio spanning health categories including sleep (Aquilea Sueño), musculoskeletal (Fisiocrem, Colagénius), respiratory (EMS, Sidroga), gastrointestinal (Aerored, Fuca, Depuralina), pediatric (Pediakid), and topical treatments (Halibut, Cistitus).

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Uriach manufactures and sells natural consumer healthcare products through more than 20 brands covering sleep (Aquilea Sueño), musculoskeletal care (Fisiocrem, Colagénius), respiratory health (EMS, Sidroga), gastrointestinal health (Aerored, Fuca, Depuralina), pediatric care (Pediakid, Bebegel), motion sickness (Biodramina), women's health (Cistitus), topical/skin care (Halibut), and weight management (Depuralina, Drenaslim), along with acquired brands Pascoe (German natural active-ingredient medicines) and Ineldéa (French pediatric naturals). Products are sold through retail pharmacies, health stores, and brand e-commerce portals in 11 European countries with direct presence and 20+ additional countries through distribution.

Product overview

Uriach is a house of brands focused on Natural Consumer Healthcare, offering a diversified portfolio of natural health and wellness products. The portfolio includes core brands like Aquilea (general wellness), Fisiocrem (muscle/joint care), Laborest (nutraceuticals), and EMS/Emsan (respiratory health via Emser salt), along with specialty brands for pediatric care (Pediakid), digestive health (Fuca, Aero-red), motion sickness (Biodramina), women's health (Cistitus), dermatology (Halibut), and weight management (Depuralina, Drenaslim). Recent acquisitions in 2024 added Pascoe (high-bioavailability Vitamin C, Germany) and Ineldéa/Pediakid (pediatric nutrition, France). The company operates across 11 European countries with 20+ brands generating €476M revenue.

Differentiator

Problem solved

Functional benefit

Brands

• Aquilea: Natural and effective self-care products for health and well-being.
• Fisiocrem
• Laborest
• EMS
• Pediakid
• Sidroga Teas
• Fuca
• Colagénius
• Depuralina
• Biodramina
• Emcur
• Aero-red
• Cistitus
• Emsan
• Drenaslim
• Halibut
• Ceregumil
• Valverde
• Utabon

Products and services

• Aquilea Natural self-care brand offering health and wellbeing products (including sleep, stress, and general wellness) for consumers seeking natural and effective solutions.
• Fisiocrem Topical natural solutions for preparing, recovering, and treating joints and muscles to enable pain-free movement.
• Laborest Advanced nutraceutical solutions based on scientific evidence, with 30+ years of experience, supporting healthcare professionals in improving patient outcomes.
• EMS (Emser) Natural respiratory health products leveraging the unique healing properties of proprietary Emser® mineral salt.
• Pediakid Natural pediatric health brand offering supplements and wellness products formulated for children.
• Sidroga Teas 100% natural medicinal teas for a range of ailments, drawing on medicinal tea expertise dating back to 1873.
• Fuca Natural solutions for occasional and chronic constipation.
• Colagénius Portuguese expert collagen brand promoting visible wellness that starts from within.
• Depuralina Portuguese reference brand in the weight loss market offering natural solutions for excess weight management.
• Biodramina Spanish market leader for the prevention and treatment of motion sickness symptoms.
• Aero-red Effective natural solution to relieve gas and reduce bloating.
• Cistitus Natural solution for the prevention and treatment of cystitis in women.
• Halibut Topical products that protect, soothe, and regenerate irritated skin for the whole family.
• Ceregumil Nutritional supplementation brand offering a unique formula with vitamins to support strength and vitality.
• Utabon Nasal decongestant that quickly and effectively relieves nasal congestion, allowing rapid ventilation of obstructed nasal passages.
• Pascoe German pharmaceutical brand specializing in medicines with natural active ingredients, particularly high-bioavailability Vitamin C (Pascorbin).
• Ineldéa (Laboratories Ineldéa) French company and leader in natural products for the pediatric segment through brands such as Pediakid.
• Bebegel Portuguese brand in the pediatric gastrointestinal segment.

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• PascoecoreStrategic or Co-development PartnerGerman pharmaceutical company specializing in medicines with natural active ingredients, particularly high bioavailability Vitamin C (Pascorbin). Acquired in 2024, enables Uriach entry into German and European markets with new brands and segments.

Scale indicators9 records

Recent moves8 records

Expansion highlights3 records

Broad incumbents

• Bayer Consumer Health: Consumer healthcare division of Bayer AG, selling OTC brands like Aspirin, Claritin, and Bepanthen globally. Represents scale competitor in adjacent OTC categories relevant to Uriach's portfolio.
• Perrigo Company: Global OTC consumer healthcare and self-care products company with extensive brand portfolio spanning cold/flu, digestive, skin care, and smoking cessation. Comparable to Uriach's house-of-brands consumer healthcare model but at much larger scale and US-rooted.
• Haleon: Global consumer healthcare spin-off of GSK with major brands like Centrum, Panadol, Voltaren, and Advil. Highly relevant comparison for branded consumer healthcare strategy, though substantially larger and more globally diversified than Uriach.
• Opella (Sanofi Consumer Healthcare): Sanofi's consumer healthcare division, recently sold to CD&R private equity. Includes brands like Doliprane, Allegra, and Dulcolax. Relevant comparison for European OTC consumer health scale, brand portfolio strategy, and PE-backed transformation.

Regional players

• Almirall: Spanish pharmaceutical company headquartered in Barcelona with both prescription dermatology and consumer healthcare products. Closest direct geographic peer to Uriach in Spain and serves overlapping pharmacy channels.
• Zambon: Italian pharmaceutical company with consumer healthcare operations across respiratory, pain, and women's health categories. Operates in overlapping European geographies (Italy, Spain, France, Switzerland, Germany) and serves similar pharmacy channels as Uriach.
• Faes Farma: Spanish pharmaceutical and consumer healthcare company with OTC and nutritional product lines sold primarily in Spain and Latin America. Comparable in size, market focus, and consumer health orientation to Uriach's Spanish operations.

Direct peers

• Omega Pharma: European consumer healthcare company headquartered in Belgium, owned by Perrigo, with broad portfolio across multiple health categories including cold/flu, intimate care, and OTC remedies. Highly comparable in European focus and multi-brand consumer health positioning.
• Dr. Wolff Group: German family-owned consumer healthcare company with brands in hair care, skin care, and oral health across European markets. Comparable in family ownership model, multi-brand portfolio strategy, and European geographic focus.
• STADA Arzneimittel: Privately-held European pharmaceutical company (backed by Bain Capital and Cinven) focused on generics and consumer healthcare across multiple European markets with a multi-brand portfolio strategy. Directly comparable to Uriach in scale, private ownership profile, and consumer healthcare orientation.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/uriach_global

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Uriach